+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Nanomedicine in Oncology. Unveiling Materials, Diagnostics, and Clinical Implications

  • Book

  • June 2026
  • Elsevier Science and Technology
  • ID: 6251035

Nanomedicine in Oncology: Unveiling Materials, Diagnostics, and Clinical Implications is a comprehensive and insightful exploration into the intersection of nanotechnology and cancer treatment. The book provides an in-depth look at the historical foundations, current advancements, and future possibilities, particularly as they apply to oncology. Sections cover both the translation of nanomedicine research into clinical practice and explore various therapeutic applications, including nanoparticle-based chemotherapy, immunotherapy, photothermal and photodynamic therapy, and gene therapy utilizing nanocarriers. Finally, the book provides concluding remarks and an outlook on continued growth and potential in oncology, summarizing key insights and looking forward to future advancements.

The book offers valuable perspectives for research and clinical application, fostering a comprehensive understanding of nanomedicine's impact on cancer treatment. It's insights and knowledge make it a globally relevant and impactful resource in the domain of nanomedicine in oncology.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. History, Foundations, and Evolution of Nanomedicine
2. Nanoparticles Eaxtensive Production: Ensuring Quality and Functionality
3. Nanoparticle or Nanodiagnostics Efficacy in Oncology: Overcoming Tumor Targeting and Penetration Barriers
4. Translating Nanomedicine Research into Clinical Practice
5. Therapeutic Applications of Nanomedicine
6. Implications of Pre-Clinical and Clinical Research on Patient Outcomes
7. Nanomedicine Regulatory and Ethical Aspects: Global Perspectives and Strategies
8. Nanomedicine Economic Development: Funding Strategies and Cost Management
9. Nanomedicine Accessibility: Strategies for Global Reach and Affordability
10. Challenges and Future Horizons in Nanomedicine
11. Concluding Remarks and OutlooK

Authors

Ajay Kumar Department of Environmental Science, Graphic Era (Deemed to be University), Dehradun, Uttarakhand, India. Dr. Ajay Kumar holds a B.Tech in Biotechnology, an M.Tech in Environmental Science and Engineering, and a Ph.D. in Life Sciences (Environmental Sciences). He is a UGC-BSR Fellow and has qualified for the National Eligibility Test (UGC-NET). Previously, he served as a Senior Project Associate at Punjab Biotechnology Incubator, Mohali. He also worked as a Postdoctoral Fellow at the University of Wisconsin-Madison, USA and as an Assistant Professor at the University Center for Research and Development (UCRD), Chandigarh University, Mohali, India. Currently, he is an Assistant Professor in the Department of Environmental Science at Graphic Era (Deemed to be University), Dehradun, Uttarakhand, India. His research interests include Cancer Chemoprevention using Natural Plant Products, Cancer Immunology, and Environmental Toxicology. He has published over 45 articles, including research papers, reviews, and book chapters, in reputable international peer-reviewed journals. Narashans Alok Sagar Assistant Professor, Department of Biotechnology, Chandigarh University, Mohali, India.

Dr. Narashasns Alok Sagar is currently serving as an Assistant Professor at the Department of Biotechnology, University Centre for Research and Development at Chandigarh University in Punjab, India. He possesses expertise in several domains, including Food Microbiology, Secondary Metabolites, Waste Valorization, Molecular Biology, Nanotechnology, and New Product Development. Dr. Sagar published over 40 contributions, encompassing research papers, review articles, book chapters, and popular articles featured in esteemed national and international peer-reviewed journals from reputable publishers.